IM Therapeutics locks in $10 mln Series A

Published: 10/10/2019
IM Therapeutics locks in $10 mln Series A
Source: WWW.PEHUB.COM

Woburn, Massachusetts-based mmunoIMolecular Therapeutics , a developer of personalized therapies for autoimmune disease, has raised $10 million in Series A financing. JDRF T1D Fund and Morningside Ventures led the round with participation from the Colorado University Healthcare Innovation Fund.

Read more
Related news
Comment
FACEBOOK